Daniel Scott The Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology 2014

Daniel Scott

Daniel completed his PhD at The University of Melbourne in 2007, supervised by Ross Bathgate and Geoffrey Tregear at the Howard Florey Institute. During this time he investigated the activation mechanisms of relaxin and INSL3 receptors. He subsequently spent 4 years as an NHMRC (Australia) CJ Martin Fellow in the laboratory of Andreas Plückthun at the University of Zurich, where he developed a new ‘directed evolution’ technology for engineering stabilised G-protein-coupled receptors. His studies lead to several crystal structures of the neurotensin receptor-1 and on the basis of this advanced biotechnology, Daniel co-founded G7 Therapeutics in 2013. He was recruited to The Florey Institute of Neuroscience and Mental Health in 2011 where he now leads a group focused on membrane protein engineering, structure and function. His current research is focused on the development of new protein engineering methods that can be applied to facilitate the application structural biology and drug design to challenging membrane protein targets

Abstracts this author is presenting: